Trade Mark Journal No.2026/039 25 September 2026

WO0000001920413 (9,38,42,44)

Office of origin: United States of America

Date of International Registration:12 February 2026
Date of designation in the UK: 12 February 2026
Image for mark 1920413

The mark consists of the word PRE in a stylized format.

International priority date claimed: 23 September 2025 (United States of America) (99409026)
Class 9
Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields.
Class 38
Telecommunications access services; telecommunication services provided via Internet platforms in the field of health; providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data.
Class 42
Research services in the field of data analytics and machine learning, namely analysis of technical data relating to clinical trials, laboratory and genomics; data mining; scientific research and machine software and artificial intelligence programming and technology consulting in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SaaS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields.
Class 44
Healthcare services, namely, medical counseling services and treatment monitoring using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the internet or telecommunication networks.

Verily Life Sciences LLC

Representative: Andrew T. Pettit Perkins Coie LLP, P.O. Box 2608, Seattle WA 98111, UNITED STATES OF AMERICA